Consistent with the effects of USP14 upon the proteasome, these USP14 aptamers enhanced proteasome activity, and facilitated the degradation of Alzheimer’s disease (AD)-implicated tau proteins. Here, USP14 is linked to early-onset autosomal dominant Alzheimer disease.